Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

28 Jan 2014 14:27

RNS Number : 7051Y
Standard Life Euro Pri Eqty Tst PLC
28 January 2014
 

 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 31 December 2013

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 October 2013 to 31 December 2013. This announcement constitutes the Company's first interim management statement for the year ending 30 September 2014 in accordance with rule 4.3 of the UK Listing Authority's Disclosure Rules and Transparency Rules. This interim statement summarises information as at 31 December 2013 and any material developments up to 28 January 2014.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's audited net asset value per ordinary share ("NAV") was 244.2p at 30 September 2013 (diluted - 243.4p). The Company's NAV at 31 December 2013 will be announced on or around 18 March 2014. The share price of the Company's ordinary shares was 204.0p at 31 December 2013, compared to 198.0p at 30 September 2013, a rise of 3.0% over the quarter. Over the same period the MSCI Europe Index (in euros) and the FTSE All Share Index (in sterling) rose by 5.6% and 4.8% respectively.

 

Financial position

 

The quarter ended 31 December 2013 saw an increase in new investment and realisation activity in the European private equity market. The value of all new private equity transactions in the European private equity market announced during the quarter was €23.6 billion (quarter ended 30 September 2013 - €16.9 billion), of which €21.1 billion comprised buy-out transactions (quarter ended 30 September 2013 - €15.4 billion).

 

Distributions received by the Company during the quarter ended 31 December 2013 were £39.7 million (quarter ended 30 September 2013 - £24.6 million) and the Company funded £9.4 million of draw downs (quarter ended 30 September 2013 - £11.2 million).

 

In line with the Company's investment strategy, a new commitment of €30.0 million was made to Nordic Capital VIII in October 2013. In addition, the Company acquired through a secondary purchase an original commitment of €20.0 million to 3i Eurofund V in December 2013. The fund interest was acquired at a 2.5% discount to the 30 June 2013 valuation of the fund, adjusted for subsequent cashflows. The unrealised valuation of the fund rose by 5.1% at the most recent valuation date, being 30 September 2013. The purchase price for the fund interest was £8.2 million and the Company assumed outstanding commitments of £0.7 million. The Company already held an existing original commitment of €40 million to 3i Eurofund V.

 

At 31 December 2013 the Company had outstanding commitments of £192.6 million to 41 private equity fund interests (30 September 2013 - £178.5 million and 40 fund interests).

 

On 11 December 2013 the Company acquired 350,000 ordinary shares in the Company, through a share buy-back transaction, for a total of £693,000. The ordinary shares were acquired at an average price of 198.0p and at a discount to the prevailing diluted NAV of 18.7%. The ordinary shares acquired have been cancelled.

 

At 31 December 2013 the Company had a cash balance, including holdings in liquidity funds, of £63.4 million (30 September 2013 - cash balance of £42.3 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Events and transactions in the subsequent period to 28 January 2014

 

During the period from 1 January to 27 January 2014 the Company received £2.0 million of distributions and funded £1.7 million of draw downs. At 27 January 2014 the Company had a cash balance, including holdings in liquidity funds, of £59.8 million and outstanding commitments of £189.4 million.

 

On 24 January 2014 the Company acquired 1,250,000 ordinary shares in the Company, through a share buy-back transaction, for a total of £2,475,000. The ordinary shares were acquired at an average price of 198.0p and at a discount to the prevailing diluted NAV of 18.7%. The ordinary shares acquired have been cancelled.

 

On 31 December 2013 the Company applied to the UK Listing Authority and the Stock Exchange for 100,000 ordinary shares to be admitted to the Official List in relation to the conversion of founder A shares. This represented the final conversion of founder A shares and the new ordinary shares were granted admission on 6 January 2014. The Company currently has 163,597,294 ordinary shares in issue.

 

At the Company's annual general meeting held earlier today shareholders approved a final dividend for the year ended 30 September 2013 of 5.0p per ordinary share. The final dividend will be paid on 30 January 2014. The cash cost of the final dividend is £8.2 million.

 

There are no other material events or transactions to announce.

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDBUDDBGSI
Date   Source Headline
4th Dec 20177:00 amRNSAnnual Financial Report
30th Nov 20174:49 pmRNSDirectorate Change
14th Nov 20177:00 amRNSEstimated Net Asset Value at 31 October 2017
9th Nov 20174:50 pmRNSHolding(s) in Company
16th Oct 20174:14 pmRNSHolding(s) in Company
13th Oct 20177:00 amRNSEstimated Net Asset Value at 30 September 2017
3rd Oct 201712:37 pmRNSQuarterly Disclosure
20th Sep 20177:00 amRNSEstimated Net Asset Value at 31 August 2017
20th Sep 20177:00 amRNSQuarterly Trading Statement
13th Sep 20175:05 pmRNSDirector Declaration
25th Aug 20174:38 pmRNSDirector/PDMR Shareholding
17th Aug 20174:08 pmRNSHolding(s) in Company
14th Aug 20177:00 amRNSEstimated Net Asset Value at 31 July 2017
10th Aug 20174:08 pmRNSDirector/PDMR Shareholding
4th Aug 20171:54 pmRNSDirector/PDMR Shareholding
4th Aug 20171:53 pmRNSDirector/PDMR Shareholding
14th Jul 20177:00 amRNSEstimated Net Asset Value at 30 June 2017
4th Jul 201712:59 pmRNSQuarterly Disclosure
3rd Jul 20172:46 pmRNSUpdate research from QuotedData
14th Jun 20177:00 amRNSEstimated Net Asset Value at 31 May 2017
7th Jun 20171:48 pmRNSDirector/PDMR Shareholding
7th Jun 20177:00 amRNSHalf-year Report
15th May 20177:00 amRNSEstimated Net Asset Value at 30 April 2017
8th May 20174:48 pmRNSHolding(s) in Company
2nd May 20171:09 pmRNSEdison update on Standard Life Private Eqty Trst
18th Apr 20177:00 amRNSEstimated Net Asset Value at 31 March 2017
4th Apr 201712:34 pmRNSQuarterly Disclosure
24th Mar 20177:00 amRNSEstimated Net Asset Value at 28 February 2017
24th Mar 20177:00 amRNSQuarterly Trading Statement
22nd Feb 201710:22 amRNSUpdate research from QuotedData
14th Feb 20177:00 amRNSEstimated Net Asset Value at 31 January 2017
7th Feb 20179:38 amRNSDirector/PDMR Shareholding
7th Feb 20179:37 amRNSDirector/PDMR Shareholding
31st Jan 20173:09 pmRNSChange of Name
24th Jan 20172:18 pmRNSResult of AGM
16th Jan 20177:00 amRNSEstimated Net Asset Value at 31 December 2016
4th Jan 20172:24 pmRNSQuarterly Disclosure
21st Dec 201612:33 pmRNSHolding(s) in Company
21st Dec 20167:00 amRNSChange of Broker
14th Dec 20167:00 amRNSEstimated Net Asset Value at 30 November 2016
5th Dec 201611:21 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSChange of Advisors
5th Dec 20167:00 amRNSEstimated Net Asset Value at 31 October 2016
5th Dec 20167:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Dec 20167:00 amRNSAnnual Financial Report
14th Nov 20167:00 amRNSEstimated Net Asset Values as at 31 October 2016
7th Nov 201611:04 amRNSEdison review: Standard Life Euro Priv Eqty Trst
14th Oct 20167:00 amRNSEstimated Net Asset Value as at 30 September 2016
10th Oct 20163:53 pmRNSDirector Declaration
6th Oct 201611:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.